Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer Surgeries
Status:
Completed
Trial end date:
2018-04-23
Target enrollment:
Participant gender:
Summary
The objective of this pilot study is to evaluate the efficacy and safety of preoperative
administration of levosimendan in patients with chronic heart failure scheduled for major
abdominal cancer surgery assuming the reduction of both perioperative morbidity and
mortality.